Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Shaw

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Molecular Microbiology|June 5, 2007
The critical role of the linear plasmid lp36 in the infectious cycle of Borrelia burgdorferiMollie W Jewett, Kevin Lawrence, Aaron C Bestor, et al.
Cell Reports. Medicine|April 16, 2025
A peek into the pipeline: Expert views on emerging therapiesIlse Dewachter, Günter U Höglinger, Daniel J Drucker, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 19, 2019
Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trialAmmar Al-Chalabi, Pamela Shaw, P Nigel Leigh, et al.
The New England Journal of Medicine|November 30, 2020
Women Physicians and Promotion in Academic MedicineKimber P Richter, Lauren Clark, Jo A Wick, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trialP Nigel Leigh, Michael Swash, Yasuo Iwasaki, et al.
Scientific Reports|July 21, 2015
LRP-1-mediated intracellular antibody delivery to the Central Nervous SystemXiaohe Tian, Sophie Nyberg, Paul S Sharp, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 9, 2014
The El Escorial criteria: strengths and weaknessesFederica Agosta, Ammar Al-Chalabi, Massimo Filippi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 1, 2014
Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosisStefan Lehnert, Julia Costa, Mamede de Carvalho, et al.
Nature Communications|July 11, 2024
Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responsesNaniye Malli Cetinbas, Travis Monnell, Jahna Soomer-James, et al.
Journal of Neurochemistry|November 23, 2006
Monoclonal antibodies that target pathological assemblies of AbetaMary P Lambert, Pauline T Velasco, Lei Chang, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Molecular Microbiology|June 5, 2007
The critical role of the linear plasmid lp36 in the infectious cycle of Borrelia burgdorferiMollie W Jewett, Kevin Lawrence, Aaron C Bestor, et al.
Cell Reports. Medicine|April 16, 2025
A peek into the pipeline: Expert views on emerging therapiesIlse Dewachter, Günter U Höglinger, Daniel J Drucker, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 19, 2019
Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trialAmmar Al-Chalabi, Pamela Shaw, P Nigel Leigh, et al.
The New England Journal of Medicine|November 30, 2020
Women Physicians and Promotion in Academic MedicineKimber P Richter, Lauren Clark, Jo A Wick, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trialP Nigel Leigh, Michael Swash, Yasuo Iwasaki, et al.
Scientific Reports|July 21, 2015
LRP-1-mediated intracellular antibody delivery to the Central Nervous SystemXiaohe Tian, Sophie Nyberg, Paul S Sharp, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 9, 2014
The El Escorial criteria: strengths and weaknessesFederica Agosta, Ammar Al-Chalabi, Massimo Filippi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 1, 2014
Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosisStefan Lehnert, Julia Costa, Mamede de Carvalho, et al.
Nature Communications|July 11, 2024
Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responsesNaniye Malli Cetinbas, Travis Monnell, Jahna Soomer-James, et al.
Journal of Neurochemistry|November 23, 2006
Monoclonal antibodies that target pathological assemblies of AbetaMary P Lambert, Pauline T Velasco, Lei Chang, et al.
Pageof 6